Amylyx Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
AMLX chart
What traders are saying about $AMLX
Latest postsAmylyx Pharmaceuticals, Inc. news
- INDV Stock Price and Chart — NASDAQ:INDV
TradingView ·
- Top Odyssey Therapeutics (ODTX) Competitors 2026
MarketBeat ·
- Can Corcept Therapeutics Stock Rally 40% After This Dip?
trefis.com ·
- Amylyx Pharmaceuticals (AMLX) Pulls Back 4.80% to $27.20, Retreating Toward Key Support - Modified Schiff
https://www.siam.in/ ·
- Amylyx Pharmaceuticals, Inc. Estimates – NASDAQ:AMLX
TradingView ·
- AMLX 261120 34.00P (AMLX261120P34000) Stock Options Chain | Quotes & News
Moomoo ·
- Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), Palvella Therapeutics (PVLA)
The Globe and Mail ·
- Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting
Yahoo Finance ·
- 3 High Growth Stocks To Own In October 2026
Yahoo Finance ·
- Amylyx Pharmaceuticals And 2 More Quality Growth Stocks
Yahoo Finance ·
- Amylyx's Avexitide Phase III Win Sets Up FDA Filing for PBH Treatment
marketbeat.com ·
- Our Pick Of The Best Growth Stocks In September 2026
Yahoo Finance ·
Amylyx Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $87.4M | $380.8M | $22.2M |
| Net income | -$144.7M | -$301.7M | $49.3M | -$198.4M |
| Diluted EPS | $-1.53 | $-4.43 | $0.70 | $-3.39 |
| Total assets (year end) | $332.6M | $193.6M | $517.5M | $391.5M |
| Cash and equivalents (year end) | $226.7M | $77.4M | $170.2M | $62.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Amylyx Pharmaceuticals, Inc.
- Ticker
- AMLX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1658551
Frequently asked questions
What exchange is Amylyx Pharmaceuticals, Inc. listed on?
Amylyx Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol AMLX.
What industry is Amylyx Pharmaceuticals, Inc. in?
Amylyx Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Amylyx Pharmaceuticals, Inc. headquartered?
Amylyx Pharmaceuticals, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Amylyx Pharmaceuticals, Inc.'s fiscal year end?
Amylyx Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Amylyx Pharmaceuticals, Inc. report?
Amylyx Pharmaceuticals, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.